Isaac Kim

PROF-TE-DIV CHIEF, Cancer Institute of New Jersey (CINJ), Urologic Oncology
FULL MEMBER, Clinical Investigations and Precision Therapeutics Program, CINJ

Emailkimiy@rutgers.edu

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Isaac Kim is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

12 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

3 Finished

NEUROENDOCRINE DIFFERENTIATION AND ENZALUTAMIDE RESISTANCE IN PROSTATE CANCER
Kim, I.
Congressionally Directed Medical Research Programs (CDMRP)
9/1/17 → 8/31/20
Project: Research project
THERAPEUTIC ROLE OF BMI-1 INHIBITORS IN ELIMINATING PROSTATE TUMOR STEM CELLS
Kim, I.
Congressionally Directed Medical Research Programs (CDMRP)
9/30/12 → 9/29/15
Project: Research project
THE DEAN AND BETTY GALLO PROSTATE CANCER CENTER: DEVELOPMENT OF SHARED RESOURCES FOR PROSTATE CANCER RESEARCH
Kim, I.
Congressionally Directed Medical Research Programs (CDMRP)
8/1/10 → 1/31/15
Project: Research project

4223 Citations
35 h-Index
171 Article
11 Comment/debate
11 Review article
4 Chapter
More

Abrogation of survival disparity between Black and White individuals after the USPSTF′s 2012 prostate-specific antigen–based prostate cancer screening recommendation
Kim, I. E., Jang, T. L., Kim, S., Modi, P. K., Singer, E. A., Elsamra, S. E. & Kim, I. Y., Dec 1 2020, In: Cancer. 126, 23, p. 5114-5123 10 p.
Research output: Contribution to journal › Article › peer-review
Adapting Urology Residency Training in the COVID-19 Era
Kwon, Y. S., Tabakin, A. L., Patel, H. V., Backstrand, J. R., Jang, T. L., Kim, I. Y. & Singer, E. A., Jul 2020, In: Urology. 141, p. 15-19 5 p.
Research output: Contribution to journal › Editorial › peer-review

Open Access

15 Scopus citations
A novel tumor suppressing gene, ARHGAP9, is an independent prognostic biomarker for bladder cancer
Piao, X. M., Jeong, P., Yan, C., Kim, Y. H., Byun, Y. J., Xu, Y., Kang, H. W., Seo, S. P., Kim, W. T., Lee, J. Y., Kim, I. Y., Moon, S. K., Choi, Y. H., Cha, E. J., Yun, S. J. & Kim, W. J., 2020, In: Oncology Letters. 19, 1, p. 476-486 11 p.
Research output: Contribution to journal › Article › peer-review

Open Access
Correction to: Unintended consequences of decreased PSA-based prostate cancer screening (World Journal of Urology, (2019), 37, 3, (489-496), 10.1007/s00345-018-2407-3)
Ahlering, T., Huynh, L. M., Kaler, K. S., Williams, S., Osann, K., Joseph, J., Lee, D., Davis, J. W., Abaza, R., Kaouk, J., Patel, V., Kim, I. Y., Porter, J. & Hu, J. C., Mar 1 2020, In: World Journal of Urology. 38, 3, p. 807 1 p.
Research output: Contribution to journal › Comment/debate › peer-review

Open Access
CXC Chemokine/Receptor Axis Profile and Metastasis in Prostate Cancer
Nagaya, N., Lee, G. T., Horie, S. & Kim, I. Y., Oct 15 2020, In: Frontiers in Molecular Biosciences. 7, 579874.
Research output: Contribution to journal › Article › peer-review

Open Access